ArticleThe journal of headache and pain2022

Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.

Bianca Raffaelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.